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ABSTRACT 
Fifteen individuals with Parkinson’s disease (PD) and impulsive compulsive behaviours (PD+ICB) 
were compared to 15 PD patients without ICBs (PD-ICB) and 15 healthy controls (HC) on a pro-
saccades and an anti-saccades task to assess if ICBs are associated with distinct saccadic 
abnormalities. PD+ICB made shorter saccades than HC and more direction errors in the anti-
saccades task than PD-ICB and HC, suggesting that patients with ICBs have greater difficulty in 
suppressing automatic saccades towards a given target. Saccadic assessment has the potential to 
evolve into a marker to guide therapeutic decisions in patients at risk of developing ICBs.  
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INTRODUCTION 
The motor abnormalities  in PD are frequently reflected in saccadic movement in the form of 
hypometria and increased reaction time (latency).1, 2 While automatic saccades appear to be 
preserved in PD,3 voluntary saccades are impaired.4-6 Although treatment with levodopa can 
improve some of these abnormalities,5 anti-saccadic reaction time and direction errors worsen as 
PD progresses.  
Impulsive compulsive behaviours (ICBs) such as the dopaminergic dysregulation syndrome, 
hypersexuality, pathological gambling, compulsive shopping and punding, affect 16% of patients 
with PD.7 Anti-saccadic error rate has been associated with impulsivity in healthy controls (HC),8 
but to date no studies have assessed eye movements of individuals with PD and ICBs (PD+ICB). The 
presence of motor and reflection impulsivity in PD+ICB9 would predict that premature saccades 
and anti-saccade direction errors are increased in these individuals. To answer this question, we 
studied pro and anti-saccades of PD+ICB and compared the results with individuals with PD 
without ICBs (PD-ICB) and HC.  
ICBs are usually underreported by PD patients10 and distinct saccadic abnormalities in PD+ICB may 
represent a novel way of identifying these behavioural abnormalities, which would be of  clinical 
value. 
 
MATERIAL AND METHODS 
Fifteen PD+ICB were matched with 15 PD-ICBs and 15 HC. Diagnosis of ICBs was based on the 
Questionnaire for Impulsive-Compulsive Disorders in Parkinson’s Disease - Rating Scale (QUIP-RS)11 
and confirmed with an interview. Patients with Montreal Cognitive Assessment (MoCA) score < 26 
were excluded. For details on other scales/questionnaires used see supplementary materials. PD 
patients using levodopa were tested one hour after intake. Eyetracking was conducted with an 
e(ye)BRAINT2 device (SuriCog). The research was approved by the local ethics committee. Two 
paradigms were created: 
. Pro-saccade task.  
Participants started focusing on a central grey dot and made a saccade to a blue dot appearing 
eccentrically (15 degrees horizontally) on the screen, displayed for 1500 milliseconds.  
. Anti-saccade task.  
Participants were instructed to focus on a central grey dot. Immediately after it disappeared, a red 
dot appeared randomly on either side of the screen 15 degrees horizontally. Participants were 
instructed to look to the opposite side of the screen and return their eyes to the central fixation 
point after the red dot disappeared, 1500 millseconds later.  
Forty randomized trials were conducted to each side, totalling 80 trials. Direction errors, saccadic 
movements towards the opposite direction of the visual stimulus, were computed as total values 
and proportion of errors in relation to the total number of detected saccades. Data points outside 
the interquartile ranges were excluded. Due to the possibility that saccades with latency >  900ms 
or < 120ms were not related to stimulus presentation, these were excluded from the analysis. 
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Saccadic parameteres were corrected for multiple comparisons using the Benjamini-Hochberg12 
method. A p value < 0.05 was considered significant. For statistical analysis details see 
supplementary materials. 
RESULTS 
There were more males in the PD+ICB (87%) and PD-ICB (80%) groups compared with HCs (47%). 
PD+ICB scored higher on the QUIP-RS, AIMS and UPDRS III. None of PD+ICB were receiving drugs 
for ICBs and no PD patients were using anticholinergics. For demographic/clinical data see table 1, 
for types of ICBs see supplementary materials. 
Table 1 – Demographic and clinical characteristics divided by group 
 PD+ICBs PD-ICBs HC p value 
N 15 15 15  
Females 2 (13.3%) 3 (20%) 8 (53.3%) 0.035* 
Age in years (SD) 53.6 ( 9.8) 54.6 ( 7.3) 53 ( 9.1) 0.880 
Average age at PD onset in 
years (SD) 
42.7 ( 10.3) 45.9 ( 7.5) - 0.344‡ 
Average PD duration in years 
(SD) 
11.1 ( 4.3) 8.7 ( 4.5) - 0.152‡ 
Current use of DA 9 (60%) 9 (60%)  1.000* 
Total DA LEDD (N = 9) (SD) 164.7 ( 133.3) 242.4 ( 96.6) - 0.178‡ 
Current use of MAOi 3 (20%) 1 (6.66%)  0.330 
Levodopa daily dose in mg 
(SD) 
743.6 ( 317.6) 605.7 ( 405.7)  0.309‡ 
Total LEDD (SD) 895.8 ( 397.5) 744.5 ( 466.2) - 0.347‡ 
Hoehn & Yahr 1: 0 
2: 15 
1: 3 
2: 12 
- 0.224 
QUIP-RS (SD) 39.9 ( 11.1) 10.07 ( 7.4) - <0.001 
AIMS (SD) 7.4 ( 4.6) 2.87 ( 3.3) - 0.005 
UPDRS III (SD) 24.6 ( 6.9) 13.73 ( 5.6) - <0.001 
MoCA (median, IQR) 28 (27; 29) 29 (27; 30) 28 (27; 29.7) 0.533 
FAB (median, IQR) 17.5 (16; 18) 18 (17; 18) 18 (18; 18) 0.089 
Demographic and clinical characteristics divided by group. SD – standard deviation;  PD – Parkinson’s disease; DA – dopamine 
agonist; LEDD – levodopa equivalent daily dose; MAOI – monoamine oxidase inhibitor; QUIP-RS - Questionnaire for Impulsive-
Compulsive Disorders in Parkinson’s Disease - Rating Scale; UPDRS III - Unified Parkinson’s Disease Rating Scale part III; AIMS - 
Abnormal Involuntary Movements Scale; MoCA - Montreal Cognitive Assessment; FAB - Frontal Assessment Battery; Ms – 
milliseconds; IQR – interquartile range.. *Chi-square test;  ANOVA; ‡ Independent samples t-test;  Kruskal-Wallis test;  
Fisher’s exact test. Significant results in bold. Results expressed in mean values and standard deviation and total values and 
proportions. 
 
The number of outlying data points excluded and premature saccades was similar between groups 
in both tasks. We found no difference between centripetal and centrifugal saccadic amplitudes in 
the pro-saccade task, and no differences in saccadic errors in the anti-saccade task between 
centripetal and centrifugal saccades, across all groups. As centripetal saccades are more influenced 
by visual determinants13, we henceforth report centrifugal saccade data only. There were no 
differences in the latency or amplitude of pro-saccades, nor anti-saccadic latency between groups. 
Anti-saccade amplitude was similar between groups (table 2), but a post-hoc analysis showed 
decreased amplitude in PD+ICB compared to HC (p = 0.021, Mann-Whitney), but no difference 
between PD+ICB and PD-ICB (p = 0.110) or between PD-ICBs and HC (p = 0.097). 
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Anti-saccadic error rate differed between groups (table 2). Post-hoc analysis revealed that PD+ICB 
made more errors than PD-ICB (p = 0.006) and HC (p = 0.001), but there was no difference between 
PD-ICB and HC (p = 0.802). Anti-saccadic reaction time for accurate saccades and direction errors 
are found in supplementary materials. 
We also analysed fixation data as this is relevant to interpretation of saccadic function. The number 
and duration of fixation deviations from the target (fixation instability) were greater in PD+ICB 
compared to PD-ICB, but this was  not statistically significant (p>0.1). There were no correlations 
between fixation instability and anti-saccadic errors, age, disease duration, UPDRSIII, AIMS or 
QUIP-RS.   
 
Table 2 – Results of the pro-saccades and anti-saccades tasks 
 PD+ICBs PD-ICBs HC p value 
N 15 15 15  
Pro-saccades task     
Total saccades (mean, 
SD) 
73.2 (76; 13) 75.8 (78; 5) 73.8 (78; 8) 0.195  
Latency in ms (median, 
IQR)  
299.9    (246.7; 
316.2) 
271.9 (246.2; 
289.4) 
264.6 (250.4; 
302.5) 
0.537  
Amplitude () 14.8 ( 2.2) 15.1 ( 2.6) 16.1 ( 2.3) 0.537  
Premature saccades 
(median, IQR) 
      9 (4; 13) 8 (2; 12) 7 (2; 10) 0.545  
     
Anti-saccades task     
Total saccades (mean, 
SD) 
77.4 (78; 5) 76.8 (79; 3) 78 (80; 2) 0.122  
Latency in ms (median, 
IQR) 
318.6 (308.6; 
359.5) 
300.2 (281.2; 
378.6) 
326.4 (285.5; 
345.4) 
0.315  
Amplitude in (median, 
IQR) 
13.5 (12; 15) 15.5 (13.8; 16.9) 16.8 (15.7; 18.5) 0.07 
Direction errors (SD) 31.1 ( 13.1)  18.9 ( 12) 15.2 ( 13.9) 0.015  
Direction errors % (SD) 48.6 ( 22) 25.2 ( 16.8) 20.7 ( 19.5) 0.006  
Premature saccades 
(median, IQR) 
1 (0; 1) 0 (0; 2) 0 (0; 1) 0.315  
Eye movements  characteristics divided by group. Direction errors are displayed as average number of direction errors 
per group (N) and as proportion of direction errors in relation to the total number of detected saccades (%). SD -
standard deviation; PD – Parkinson’s disease; ms – milliseconds.  ANOVA;  Kruskal-Wallis test; Significant results in 
bold. Benjamini Hochberg correction for multiple comparisons used for all results. Results expressed in mean values and 
standard deviation (SD) for variables with normal distribution or mean values and median and interquartile range (IQR) 
for variables with non-normal distribution. 
 
DISCUSSION 
This is the first study of saccades in PD+ICB. Corroborating previous findings showing preserved 
automatic saccades in PD,3-6 ICB does not influence pro-saccadic behaviour. The superior colliculus 
(SC) is the point of convergence for cortical and subcortical structures that influence saccadic 
control1 and is modulated by the basal ganglia.14 This structure is under tonic inhibiton from the 
substantia nigra pars reticulata (SNr). Cortical visual signals are initially directed to the caudate, 
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which connects to the SNr via direct and indirect pathways. The former inhibits the SNr and release 
the SC to perform a saccade, whereas the latter increases SC inhibition preventing the generation 
of saccades towards ‘valueless’ objects.14, 15 The SNr is affected later in PD,16 therefore integrity of 
such pathways in early PD could explain the preservation of pro-saccades. It is unlikely that 
dopaminergic medication contributed to this as levodopa slows reaction time of pro-saccades.5, 17 
However, it is possible that the sample size was insufficient to detect subtle differences. 
Contradictory data on anti-saccadic reaction time in PD has been published.3 Here, all patients 
were were tested during ON which may explain the lack of differences in anti-saccadic latencies. 
The amplitude of anti-saccades, however, was lower in PD+ICB compared to HC. We were unable 
to replicate findings of previous reports which found that PD-ICB have hypometric saccades.3 As 
previously described in a PD population, saccadic hypometria is unaffected by levodopa use.5  
More premature saccades were made in the pro-saccades than the anti-saccades task. It has been 
shown that anticipatory saccadic movements can occur with predictable tasks similar to our pro-
saccade paradigm.18 Increased anti-saccadic error rate has been reported in drug-naïve PD,19 but 
the error rate found here was higher than previously reported, possibly due different assessment 
protocols. Whereas PD+ICB made more direction errors than both groups, there were no 
differences between PD-ICB and HC. This is unlikely to be related to abnormalities of fixation, given 
similar rates of fixation instability across both groups. 
PD+ICBs have reflection impulsivity, temporal discounting and a bias towards risky choices in 
decision-making tasks.9 However, considering the short time between target onset and saccadic 
movement and the low number of premature saccades, it is unlikely that decision-making 
abnormalities are behind the higher error rate in PD+ICB. Previous studies show that correct 
performance in the anti-saccadic task requires top-down inhibition of neurons in the SC before 
target onset.1 PD-related dopaminergic depletion in the dorsolateral prefrontal cortex coupled 
with deficits in cortical inhibitory circuits in PD+ICB20 may explain the failure to suppress an 
automatic saccade.21  
An important caveat is that PD+ICB had higher UPDRS scores, which could contribute to increased 
anti-saccadic error rate; both anti-saccadic error rate and reaction time increase as PD 
progresses.22, 23 However, there are important differences between our study and previous reports 
of saccadic abnormalities in advanced PD. Firstly, in our study PD+ICB exhibited a significantly 
higher error rate (48.62%) compared to the literature (36.2%).23 Secondly, in our study the anti-
saccadic reaction time was also shorter (318.6ms) than a previous report (410ms).23 Thirdly, 
severity of bradykinesia has been correlated with longer anti-saccadic latencies23 but we have 
found no differences in reaction time between PD+ICB and PD-ICB. Lastly, direction errors were not 
correlated with QUIP-RS, AIMS nor UPDRS scores. Therefore, although the UPDRSIII suggests that 
PD+ICB have more advanced PD, the anti-saccades data do not corroborate this. Although the 
UPDRSIII score influences performance in PD-ICB23 it is likely that cognitive impulsivity is 
contributing to poor performance in PD+ICB.  
One limitation of this study is the small sample size. This was addressed by sampling 80 saccades in 
each task, ensuring patients were offered breaks between tasks to avoid fatigue. There were more 
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female HC; previous data show that saccadic parameters do not differ between sexes,24 although 
one study reported a higher anti-saccadic error rate in women compared to men.25 However, the 
20% error rate of HC in our study is lower than the findings of that study.  
This is the first study of saccades in PD+ICBs, who made hypometric anti-saccades and a higher 
number of anti-saccade direction errors.  This finding may have important clinical implications if 
antisaccadic error rate could be confirmed as a marker for ICBs. Future studies should investigate 
whether PD+ICB are less able to inhibit saccades to less salient stimuli. Tasks with short 
preparation times, or which present sensory information before motor choice, could help 
understanding decision-making in such a short time frame and the health of the frontal inhibitory 
circuits modulating it.26, 27 
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Supplementary Material - Saccadic direction errors are associated with impulsive compulsive 
behaviours in Parkinson’s disease patients. 
 
Methodology 
 
All PD patients fulfilled the Queen Square Brain Bank diagnostic criteria.1 
 
The diagnosis of ICBs was made based on the Questionnaire for Impulsive-Compulsive Disorders in 
Parkinson’s Disease - Rating Scale (QUIP-RS) scores using previously published cutoff values2 and 
confirmed with a semi-structured interview.  
 
 All participants were assessed with the following questionnaires and scales: the MoCA and the 
Frontal Assessment Battery (FAB). Patients were also assessed with the QUIP-RS, the Unified 
Parkinson’s Disease Rating Scale (UPDRS) part III and the Abnormal Involuntary Movements Scale 
(AIMS). 
 
To ensure PD patients were tested in the ON state, patients on levodopa were assessed one hour 
after taking levodopa. Eye movements assessments were carried out with an e(ye) BRAIN T2 
device. Before each task a twelve-point calibration of the eyetracker infrared cameras and 
automated calibration of the head sensor were conducted. 
 
. Pro-saccades task details. 
Participants started by focusing on a grey dot measuring 0.32 degrees of visual angle on the centre 
of the screen. They were then instructed to make a saccade to a blue dot appearing eccentrically (15 
degrees from centre) on the screen, displayed for 1500 milliseconds (ms). The central grey dot 
remained on display throughout the assessment. After 1500 ms, the blue dot disappeared and 
patients had to return their eyes to the central fixation dot. 
 
. Anti-saccades task details.  
Participants were instructed to focus on a central grey dot measuring 0.32 degrees of visual angle 
that was displayed for 1500 ms. In this task a step paradigm was used. Immediately after the grey 
dot disappeared, without delay, a red dot appeared randomly on either side of the screen 15 degrees 
away from the centre. 
 
Data analysis was conducted initially with the e(ye) BRAIN software me(ye) analysis. The computer 
was programmed to identify the first saccadic movement occurring after the target appeared that 
exceeded a speed of 30 degrees per second. The quality of the recording from both eyes was 
inspected visually by one of the authors (PB), and the channel with best recording chosen for data 
analysis. A poor quality signal was identified when there was too much interference to prevent 
accurate detection of saccades and/or when the computer failed to identify more than 75% of the 
expected saccadic movements, in both cases recordings were excluded from analysis. Latency and 
gain were calculated for each detected saccade and mean values used for comparison. 
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Considering that normal subjects generate a saccade within approximately 200 ms,3 saccades with 
latencies between 120 and 180 ms were classified as premature and included in the analysis. 
Saccadic amplitude was calculated as average of all saccades. The number of direction errors in the 
anti-saccades task was calculated for each participant and mean values used for comparison. 
Parametric data was compared using independent samples t-test and ANOVA and non-parametric 
Kruskal-Wallis. Mann-Whitney U test and Wilcoxon matched pairs were used for post hoc 
comparison of saccadic parameters. Proportions were compared with the chi-square test, except if 
expected cell count was less than 5 when Fisher’s exact test was used 
 
Results 
 
Six patients with PD were excluded: two because of low MoCA scores, three because of poor quality 
of recording and one because of a technical fault with the computer processing unit. One healthy 
individual was excluded because of poor quality of the recording. Fifteen patients were included in 
each group: patients with PD and ICBs (PD+ICBs), patients with PD without ICBs (PD-ICBs) and healthy 
controls (HC). An example of raw data is displayed in figures 1 and 2. 
 
 
Figure 1. Raw data of one patient with ICB (left image), one patient without ICB (middle image) and 
one healthy individual (right image). PD+ICB made a significantly higher number of direction errors 
(red circles). X axis represents time and y axis amplitude. 
 
 
Figure 2. Raw data of one patient with ICB showing direction errors (red circles) and X axis represents 
time and y axis amplitude. 
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In the PD+ICB group 5 patients had a single ICB (2 compulsive sexual behaviour (CSB), 2 
punding/hobbyism (Pu) and 1 compulsive shopping) (CS) and 10 multiple ICBs (2 CSB with compulsive 
eating (CE), 1 CSB with pathological gambling (PG), 1 Pu with CS, 2 Pu with CE, 1 CSB with CS, 1 CSB 
with CS and CE, 1 with CS, CE and Pu, and 1 with PG, CS and HP. 
 
Anti-saccades that generated a direction error had shorter reaction times as seen in figure 3. 
 
 
Figure 3. Latency of anti-saccades that were accurate and that were associated with a direction error. 
No differences between groups were observed. Within group comparison revealed shorter reaction 
times of saccades that were associated with a direction error. *Wilcoxon matched pairs. 
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